By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Acetylon Pharmaceuticals 

Seaport Center
70 Fargo Street, Suite 205
Boston  Massachusetts  02210  U.S.A.
Phone: 617-245-1300 Fax: 617-245-1301




Company News
Acetylon Presents Early Phase 1a/1b Results For Citarinostat (ACY-241) In Combination With Pomalyst And Dexamethasone Showing Promising Treatment Responses In Relapsed Or Relapsed-And-Refractory Multiple Myeloma 12/5/2016 1:13:29 PM
Acetylon Presents Preclinical Data Demonstrating The Utility Of Selective HDAC1,2 Inhibition By ACY-957 To Induce Gamma Globin (HBG) Protein Expression For The Treatment Of Sickle Cell Disease And Beta-Thalassemia 12/5/2016 10:11:16 AM
Boston's Acetylon Gets Taken Out By Celgene (CELG), Will Spin Out Startup Regenacy Pharma 12/5/2016 5:51:44 AM
Acetylon Announces Upcoming Scientific Presentations On The Use Of Selective HDAC Inhibitors In Treating Genetic Blood Disorders And Cancers 12/2/2016 9:56:51 AM
Celgene (CELG) Passes on Option-to-Buy $600 Million Deal for Boston's Acetylon 8/8/2016 7:21:21 AM
Acetylon Pharmaceuticals Presents Data On The Use Of HDAC6 Inhibitors Ricolinostat (ACY-1215) And ACY-241 In Combination With Pomalidomide And Dexamethasone For The Treatment Of Multiple Myeloma 6/13/2016 9:58:23 AM
ASCO2016: Acetylon Pharmaceuticals Collaborators Publish ASCO Abstracts Demonstrating Immunomodulatory Properties Of Ricolinostat In Preclinical Melanoma Models 6/3/2016 11:52:38 AM
Acetylon Pharmaceuticals Publishes New Mechanism For The Treatment Of Sickle Cell Disease/Beta-Thalassemia With Selective HDAC1/2 Inhibition In Plos One 5/4/2016 8:29:09 AM
Acetylon Pharmaceuticals Announces The Presentation Of Preclinical Data At AACR Supporting The Use Of Selective HDAC6 Inhibition To Modulate Chronic Lymphocytic Leukemia (CLL) Immunobiology 4/20/2016 11:32:03 AM
Acetylon Pharmaceuticals Presents Data From Three Phase Ib Studies Of Ricolinostat (ACY-1215) For The Treatment Of Lymphoma And Multiple Myeloma 12/7/2015 10:36:02 AM